ProShares UltraShort NASDAQ Biotechnology
5 hedge funds and large institutions have $629K invested in ProShares UltraShort NASDAQ Biotechnology in 2025 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 0 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
5
Holders Change
+1
Holders Change %
+25%
% of All Funds
0.07%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
2
Reduced
2
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$186K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$3.84K |
Top Sellers
| 1 |
Morgan Stanley
New York
|
-$1.74K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$903 |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $557K | +$186K | +10,520 | +50% |
|
|
TRCT
2
Tower Research Capital (TRC)
New York
| $67.7K | -$903 | -51 | -1% |
|
|
3
UBS Group
Zurich,
Switzerland
| $3.86K | +$3.84K | +217 | +21,700% |
|
|
4
Morgan Stanley
New York
| $47 | -$1.74K | -74 | -97% |
|